Similar Items: Treatment of HIV associated neurocognitive disorders
- HIV-associated neurocognitive disorders
- HIV-associated neurocognitive disorders biomarkers and the response to antiretroviral therapy
- The role of the astrocytic marker S100B in HIV-associated neurocognitive disorders
- An investigation of a neuro-inflammatory profile of HIV-associated neurocognitive disorders
- Analysis of HIV-1 diversity and inflammatory markers in HIV-associated neurocognitive disorders (HAND).
- Proteomic investigation of blood-based biomarkers for the diagnosis of HIV-associated neurocognitive disorders
Author: Maartens, Gary
- The evaluation of different strategies to improve the diagnosis of tuberculosis in people living with HIV in resource-limited settings
- The pharmacokinetics of lopinavir in HIV-infected adults receiving rifampicin with adjusted doses of lopinavir
- The prognosis of tuberculosis in adults infected with Human Immunodeficiency Virus (HIV-1)
- Safety and effectiveness of colistin compared with tobramycin for multi-drug resistant Acinetobacter baumannii infections
- The efficacy of intermittent directly observed isoniazid in preventing tuberculosis in HIV-infected adults with advanced disease
- Tuberculous pleural effusions : a prospective study of rapid diagnostic tests (adenosine deaminase, antigen capture enzyme-linked immunosorbent assay, and the polymerase chain reaction) and evaluation of a radiometric mycobacterial culture system